Optimal first-line therapy for NSCLC with EGFR mutations
Year: 2010
Type: article
Source: Nature Reviews Clinical Oncology
Authors: Joel W. Neal, Lecia V. Sequist
Institutions: Harvard University, Massachusetts General Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2025664731